Vaccines, Blood & Biologics
-
Spherusol
STN: 125354
Proper Name: Coccidioides immitis Spherule - Derived Skin Test Antigen
Tradename: Spherusol
Manufacturer: Allermed Laboratories, Inc., License #467
Indication:
- For the detection of delayed type hypersensitivity to C. immitis in individuals, 18-64 years of age, with a history of pulmonary coccidioidomycosis.
-
Supporting Documents
July 29, 2011 Approval Letter - Spherusol
Coccidioides immitis Spherule - Derived Skin Test Antigen is indicated for the detection of delayed type hypersensitivity to C. immitis in individuals, 18-64 years of age, with a history of pulmonary coccidioidomycosis.Summary Basis for Regulatory Action, June 28, 2011 - Spherusol (PDF - 153KB)Approval History, Letters, Reviews and Related Documents - Spherusol
-
-
Related Information
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-